An International Journal of Otorhinolaryngology Clinics

Register      Login

VOLUME 3 , ISSUE 1 ( January-April, 2011 ) > List of Articles

REVIEW ARTICLE

Management of Vestibular Schwannoma: Dependence on Stakeholder's View for Small and Medium-Sized Tumors

Maria Zisiopoulou, Haralampos Gouveris, Wolf J Mann

Keywords : Decision,Evidence,Management,Observation,Radiation,Surgery,Schwannoma,Vestibular

Citation Information : Zisiopoulou M, Gouveris H, Mann WJ. Management of Vestibular Schwannoma: Dependence on Stakeholder's View for Small and Medium-Sized Tumors. Int J Otorhinolaryngol Clin 2011; 3 (1):7-13.

DOI: 10.5005/jp-journals-10003-1049

Published Online: 01-04-2011

Copyright Statement:  Copyright © 2011; Jaypee Brothers Medical Publishers (P) Ltd.


Abstract

Management options for patients with vestibular schwannoma include observation and active treatment, namely surgical resection, gamma knife stereotactic radiosurgery or fractionated radiation therapy. Although for large tumors microsurgery remains the mainstay of treatment, management of the small- and medium-sized vestibular schwannomas has been the matter of considerable controversy. Computerized clinical decision support systems have been developed to assist clinicians in this demanding task. Nonetheless, the complexity of the problem requires adaptation of the decision strategy to specific circumstances arising within a particular clinical scenario which can not always be modeled with adequate precision or addressed adequately within a mathematical framework. We present a set of clinical, neurophysiologic and radiologic parameters and the respective evidence which may guide carers’ decisions. These parameters include the size, growth rate and localization of the tumor, the age, general medical condition, facial nerve function, hearing and hearing deterioration rate, balance, vestibular and trigeminal nerve function of the affected individual, the estimated risk of malignant transformation and radiation-induced tumors, the health-related quality of life measures, the patient's and surgeon's preference and the issue of cost-effectiveness. A complex decision analysis, guided by evidence and tailored to each individual patient is required.


PDF Share
  1. New and modified reporting systems from the consensus meeting on systems for reporting results in vestibular schwannoma. Otol Neurotol 2003;24:642–48.
  2. Conservative management of 386 cases of unilateral vestibular schwannoma: Tumor growth and consequences for treatment. J Neurosurg 2009;110:662–69.
  3. A protocol for the conservative management of vestibular schwannomas. Otol Neurotol 2009;30:381–85.
  4. Growing vestibular schwannomas: What happens next? Otol Neurotol 2009;30: 101–04.
  5. Conservative management of acoustic neuroma: An outcome study. Neurosurgery 1996;39:260–64.
  6. Vestibular schwannoma: An understanding of growth should influence management decisions. Otol Neurotol 2008;29:829–34.
  7. The natural history of untreated sporadic vestibular schwannomas: A comprehensive review of hearing outcomes. J Neurosurg 2010;112:163–67.
  8. Management of vestibular schwannomas that enlarge after stereotactic radiosurgery: Treatment recommendations based on a 15-year experience. Neurosurgery 2006; 58:241–48.
  9. Hearing preservation after intracanalicular vestibular schwannoma radiosurgery. Neurosurgery 2008;63:1054–62.
  10. Conservative management of vestibular schwannomas: Third review of a 10-year prospective study. Clin Otolaryngol 2008;33:255–59.
  11. Management of acoustic neuromas in patients 65 years or older. Otol Neurotol 2007;28:708–14.
  12. Acoustic neuromas in the elderly. Otol Neurotol 2001;22:389–91.
  13. Gamma knife radiosurgery in younger patients with vestibular schwannomas. Neurosurgery 2009;65:294–300.
  14. Management of vestibular schwannomas in young patients: Comparison of clinical features and outcome with adult patients. Childs Nerv Syst 2007;23:891–95.
  15. Facial nerve preservation after vestibular schwannoma gamma knife radiosurgery. J Neurooncol 2009;93:41–48.
  16. Influence of different approaches to the cerebellopontine angle on the function of the intermediate nerve. J Neurosurg 2007;107:927–31.
  17. Conservative management of vestibular schwannomas: An effective strategy. Laryngoscope 2008; 118:951–57.
  18. Dynamic posturography findings predict balance status in vestibular schwannoma patients. Otol Neurotol 2007;28:372–75.
  19. Untreated vestibular schwannomas: Vertigo is a powerful predictor for health-related quality of life. Neurosurgery 2006;59:67–76.
  20. Clin Otolaryngol 2007;32:167–72.
  21. Influence of nerve of origin and tumor size of vestibular schwannoma on dynamic posturography findings. Acta Otolaryngol 2006;126:1281–85.
  22. Vestibular function after acoustic neuroma removal with preservation of one branch of the vestibular nerve. Otol Neurotol 2002;23:749–54.
  23. Treatment of acoustic neuroma: Stereotactic radiosurgery vs. microsurgery. Int J Radiat Oncol Biol Phys 2002;54:1410–21.
  24. Malignant transformation of a vestibular schwannoma after gamma knife radiosurgery. Lancet 2002;360:309–10.
  25. Malignant peripheral nerve sheath tumor arising from benign vestibular schwannoma treated by gamma knife radiosurgery after two previous surgeries: A case report with surgical and pathological observations. World Neurosurg 2010;73:751–54.
  26. Malignant transformation and new primary tumours after therapeutic radiation for benign disease: Substantial risks in certain tumour prone syndromes. J Med Genet 2006;43: 289–94.
  27. Malignant peripheral nerve sheath tumours, radiotherapy and neurofibromatosis 2. Br J Cancer 2000;82:998.
  28. Intracranial sarcoma in a patient with neurofibromatosis type 2 treated with gamma knife radiosurgery for vestibular schwannoma. Am J Otol 2000;21:364–70.
  29. Long-term outcomes in patients with vestibular schwannomas treated using gamma knife surgery: 10-year follow-up. J Neurosurg 2005;102:10–16.
  30. Twenty years’ experience in the treatment of acoustic neuromas with fractionated radiotherapy: A review of 45 cases. Int J Radiat Oncol Biol Phys 2006;66:170–78.
  31. A true malignant schwannoma of the eighth cranial nerve: A case report. Neurosurgery 2007;6:E421–22.
  32. Radiation-induced tumor after stereotactic radiosurgery and whole brain radiotherapy: Case report and literature review. J Neurooncol 2004;66:301–05.
  33. Illness perceptions, coping and quality of life in vestibular schwannoma patients at diagnosis. Otol Neurotol 2008;29:839–45.
  34. Some aspects of life quality after surgery for acoustic neuroma. Arch Otolaryngol Head Neck Surg 1992;118:1061–64.
  35. Quality of life in sporadic vestibular schwannoma: A review. ORL J Otorhinolaryngol Relat Spec 2010;72:69–74.
  36. Decision analysis of treatment options for vestibular schwannoma. J Neurosurg 2011;114:400–13.
  37. Mapping clinical outcomes expectations to treatment decisions: An application to vestibular schwannoma management. Otol Neurotol 2010; 31:284–93.
  38. Comparison of the surgical and follow-up costs associated with microsurgical resection and stereotactic radiosurgery for vestibular schwannoma. J Neurosurg 2008;108:1220–24.
  39. Evaluation of cost effectiveness for conservative and active management strategies for acoustic neuroma. Clinical Otolaryngology 2009; 34:438–46.
  40. Management of the small acoustic neuroma: A decision analysis. Am J Otol 1994;15:358–65.
  41. Management of patients with acoustic neuromas: A Markov decision analysis. Laryngoscope 2010;120:783–90.
  42. American Academy of Otolaryngology-Head and Neck Surgery Foundation, Inc. Otolaryngol Head Neck Surg 1995;113:179–80.
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.